READ Act

Monitoring legislation affecting asbestos litigation - H.R. 526 and S.357, Furthering Asbestos Claim Transparency Act, legislation imposing public reporting requirements on Asbestos Trusts Monitored legislation affecting tort reform H.R. 1927, Fairness in Class Actions Litigation and Furthering Asbestos Claim Transparency Act H.R.2030-READ Act, legislation to establish a public database and public disclosure of asbestos-containing products

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

Monitoring legislation affecting asbestos litigation - H.R. 526 and S.357, Furthering Asbestos Claim Transparency Act, legislation imposing public reporting requirements on Asbestos Trusts Monitored legislation affecting tort reform H.R. 1927, Fairness in Class Actions Litigation and Furthering Asbestos Claim Transparency Act H.R.2030-READ Act, legislation to establish a public database and public disclosure of asbestos-containing products

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

Monitoring legislation affecting asbestos litigation - H.R. 526 and S.357, Furthering Asbestos Claim Transparency Act, legislation imposing public reporting requirements on Asbestos Trusts Monitored legislation affecting tort reform H.R. 1927, Fairness in Class Actions Litigation and Furthering Asbestos Claim Transparency Act H.R.2030-READ Act, legislation to establish a public database and public disclosure of asbestos-containing products

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections; S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections; H.R.2576 - TSCA Modernization Act of 2015, all sections; and H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections.

Client expense: $7,452 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections; S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections; H.R.2576 - TSCA Modernization Act of 2015, all sections; and H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections.

Client expense: $211,173 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 01-19-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 01-19-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety. H.R. 1062/S. 571 (Pilot's Bill of Rights 2); amends the Pilot's Bill of Rights to facilitate appeals and to apply to other certificates issued by the Federal Aviation Administration, to require the revision of the third class medical certification regulations issued by the Federal Aviation Administration.

Monitoring legislation affecting asbestos litigation - H.R. 526 and S.357, Furthering Asbestos Claim Transparency Act, legislation imposing public reporting requirements on Asbestos Trusts Monitored legislation affecting tort reform H.R. 1927, Fairness in Class Actions Litigation and Furthering Asbestos Claim Transparency Act H.R.2030-READ Act, legislation to establish a public database and public disclosure of asbestos-containing products

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $20,518 · Firm income: Not reported

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $110,419 · Firm income: Not reported

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-19-2015; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-19-2015; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. S. 1900/H.R. 3830 (Bipartisan Congressional Trade Priorities Act); establishes Congressional trade negotiating objectives and enhanced consultation requirements for trade negotiations, provides for consideration of trade agreements, and for other purposes. S. 2171 (Location Privacy Protection Act); specific interest in limitations on liability and preemption of state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 4921; provides for the revision of certification requirements for the labeling of certain electronic products under the Energy Star program. S. 2615; establishes criminal penalties for failing to inform and warn of serious dangers. H.R. 4 (Jobs for America Act); revises Federal law to improve the conditions necessary for economic growth and job creation. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 3020/S. 1695 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016); making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2016. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety.

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $44,850 · Firm income: Not reported

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $184,647 · Firm income: Not reported

Bill_Number_or_Executive_Action_and_Name Child Nutrition child nutrition hearing Child Nutrition Reauthorization CHIP Excise Tax H.R.2: Medicare Access and CHIP Reauthorization Act of 2015 H.R.2030: Reducing Exposure to Asbestos Database (READ) Act H.R.769 - Safeguarding Classrooms Hurt by ObamaCare's Obligatory Levies Health Care S.1083 : Medicare Drug Savings Act of 2015 Senate Ag Cmte hearing on child nutrition

Client expense: $608,000 · Firm income: Not reported

Government targets: Education, Dept of, Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, White House Office

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database (READ) Act of 2015, all sections; and H.R.526 and S.357 - Furthering Asbestos Claim Transparency (FACT) Act, all sections.

Client expense: $51,797 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; H.R.526 and S.357 - Furthering Asbestos Claim Transparency (FACT) Act, all sections; and S. ___ - Legislation to address health risks posed by flame retardant chemicals.

Client expense: $180,613 · Firm income: Not reported

H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-17-2015; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-17-2015; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. S. 1999/H.R. 4068 (SCRA Rights Protection Act of 2014); amends the Servicemembers Civil Relief Act to require the consent of parties to contracts for the use of arbitration to resolve controversies arising under the contracts and subject to provisions of such Act and to preserve the rights of servicemembers to bring class actions under such Act, and for other purposes. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); requires foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. S. 1900/H.R. 3830 (Bipartisan Congressional Trade Priorities Act); establishes Congressional trade negotiating objectives and enhanced consultation requirements for trade negotiations, provides for consideration of trade agreements, and for other purposes. S. 2171 (Location Privacy Protection Act); specific interest in limitations on liability and preemption of state-based causes of action. S. 2393 (Servicemember Employment Protection Act); makes unenforceable any clause of an agreement between an employer and employee requiring arbitration of a dispute arising under the Uniformed Services Employment and Reemployment Rights Act (USERRA). Provides an exception when both parties voluntarily agree to arbitration. Requires any issue as to whether such requirement applies to an arbitration clause to be determined by federal law and the validity or enforceability of an agreement to arbitration to be determined by a court rather than an arbitrator. H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 4921; provides for the revision of certification requirements for the labeling of certain electronic products under the Energy Star program. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. S. 2615; establishes criminal penalties for failing to inform and warn of serious dangers. H.R. 4 (Jobs for America Act); revises Federal law to improve the conditions necessary for economic growth and job creation. General lobbying regarding altering CFPB's operational structure and rulemaking authority. General lobbying on aviation safety. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S. 852 (A Voice for Victims Act); provides that employment-related arbitration agreements shall not be enforceable with respect to any claim related to a tort arising out of rape. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 3020/S. 1695 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016); making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2016. Lobbying with regard to mandatory arbitration clauses in nursing home residency contracts.

HR 2030- READ Act; support for public database of products containing asbestos

Client expense: $690,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

SUPPORT FOR S.271 "RETIRED PAY RESTORATION ACT;" SUPPORT FOR HR.454 "MILITARY RETIREE SURVIVOR COMFORT ACT;" SUPPORT FOR HR.303 "RETIRED PAY RESTORATION ACT;" SUPPORT FOR S.743 AND H.R. 1384, HONOR AMERICA'S GUARD-RESERVE RETIREES ACT OF 2015;" SUPPORT FOR HR 1594 AND S. 979 "MILITARY SURVIVING SPOUSE EQUITY ACT;" SUPPORT FOR H.R.800 "EXPRESS APPEALS ACT;" SUPPORT FOR S.1085 "MILITARY AND VETERANS CAREGIVER SERVICES IMPROVEMENT ACT;" ALL VETERANS ISSUES IN THE NDAA (S.1376), GENERALLY; OPPOSE CUTS TO THE MILITARY COMMISSARY PROGRAM INCLUDED IN THE DOD FY 2016 BUDGET (S.1376); EDUCATION PROGRAMS INCLUDED IN THE "MILITARY COMPENSATION AND RETIREMENT MODERNIZATION COMMISSION (MCRMC) REPORT; SUPPORT FOR H.R. 501 "THE VETERANS AND SERVICE MEMBERS EMPLOYMENT RIGHTS N HOUSING ACT OF 2015;" SUPPORT OF S.602 &H.R.1141 "GI BILL FAIRNESS ACT OF 2015; OPPOSE AMENDMENT SEC. 583 OF THE NATIONAL DEFENSE AUTHORIZATION ACT, H.R. 1735 "AWARD OF PURPLE HEART TO MEMBERS OF THE ARMED FORCES WHO WERE VICTIMS OF THE OKLAHOMA CITY, OKLAHOMA, BOMBING; SUPPORT FOR AMENDMENT TO NDAA, HR 1735, TO PROTECT SERVICE MEMBERS FROM PREDATORY LENDING PRACTICES BY PAYDAY LOAN LENDERS. (REP. DUCKWORTH); SUPPORT FOR S.1117 AND H.R.2047 "ENSURING VETERANS SAFETY THROUGH ACCOUNTABILITY ACT" SUPPORT FOR H.R.1994 "TO AMEND TITLE 38, USC, TO PROVIDE FOR THE REMOVAL OR DEMOTION OF EMPLOYEES OF THE DEPT. OF VETS AFFAIRS BASED ON PERFORMANCE OR MISCONDUCT, AND FOR OTHER PURPOSES;" SUPPORT OF HR 1769 AND S. 901 "TOXIC EXPOSURE RESEARCH ACT OF 2015;" SUPPORT "SURVIVING SPOUSES BENEFIT IMPROVEMENT ACT OF 2015;" SUPPORT FOR H.R. 2531 "THE MILITARY SPOUSES' ACHIEVING COLLEGE EDUCATION FOR SURVIVORS (ACES) ACT;" SUPPORT OF AN AMENDMENT TO H.R. 1735, NDAA THAT WOULD REQUIRE DOD TO DO A STUDY, RATHER THAN PILOT PROGRAM ON PRIVATIZING COMMISSARIES; SUPPORT FOR HR 2030 "REDUCING EXPOSURE TO ASBESTOS DATABASE (READ) ACT;" SUPPORT FOR S. 979 "TO AMEND TITLE 10. USC TO REPEAL THE REQUIREMENT FOR REDUCTION OF SURVIVOR ANNUITIES UNDER THE SURVIVOR BENEFIT PLAN BY VETERANS' DEPENDENCY AND INDEMNITY COMPENSATION AND FOR OTHER PURPOSES;" SUPPORT OF HR 1338 "THE DIGNIFIED INTERMENT OF OUR VETERANS ACT OF 2015;" SUPPORT FOR HR 2934 "ADVOCATING FOR HOMELESS VETERANS ACT;" OPPOSE HR 526 "FACT ACT;" OPPOSE LANGUAGE IN H.R. 1735 (NDAA) THAT WOULD AUTHORIZE PURPLE HEART MEDAL FOR MILITARY VICTIMS OF THE OKLAHOMA CITY BOMBING IN 1995; RECOMMENDED CHANGES TO THE NDAA FOR 2015 (HR 1735).